Dosing Considerations for Antibodies Against COVID-19

At present, no cure is available for COVID-19 but vaccines, antiviral drugs, immunoglobulins, or the combination of immunoglobulins with antiviral drugs have been suggested and are in clinical trials. The purpose of this paper is to discuss the role of a pharmacokinetic and viral load analysis as a...

Descripción completa

Detalles Bibliográficos
Autores principales: Tegenge, Million A., Mahmood, Iftekhar, Struble, Evi, Golding, Basil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705402/
https://www.ncbi.nlm.nih.gov/pubmed/33259037
http://dx.doi.org/10.1007/s40268-020-00330-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705402/
https://www.ncbi.nlm.nih.gov/pubmed/33259037
http://dx.doi.org/10.1007/s40268-020-00330-3

Ejemplares similares